Significant differences were observed in the distribution of prognostic factors, with a higher percentage of advanced stages, poorly differentiated, and an absence of hormonal receptors among the patients with interval cancer, followed in frequency by patients with incident and prevalent cancer, respectively. Here, NR4A1 is linked to cancer.